cabozantinib
98%
- Product Code: 50916
CAS:
849217-68-1
| Molecular Weight: | 501.52 g./mol | Molecular Formula: | C₂₈H₂₄FN₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD20926324 | |
| Melting Point: | Boiling Point: | 758.075°C | |
| Density: | 1.397 g/mL | Storage Condition: | room temperature, dry |
Product Description:
Cabozantinib is primarily used in the treatment of advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). It works by inhibiting multiple tyrosine kinases, which are involved in the growth and spread of cancer cells. This targeted therapy helps slow tumor progression and can improve survival rates in patients. Additionally, cabozantinib is being studied for its potential in treating other types of cancers, such as thyroid cancer and prostate cancer, due to its ability to block pathways critical for tumor growth and angiogenesis. It is typically administered orally, allowing for convenient outpatient treatment.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white solid |
| PURITY | 97.5-100 |
| NMR | Consistent with structure |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿790.00 |
+
-
|
| 0.100 | 10-20 days | ฿1,980.00 |
+
-
|
| 0.250 | 10-20 days | ฿3,520.00 |
+
-
|
| 1.000 | 10-20 days | ฿7,500.00 |
+
-
|
cabozantinib
Cabozantinib is primarily used in the treatment of advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). It works by inhibiting multiple tyrosine kinases, which are involved in the growth and spread of cancer cells. This targeted therapy helps slow tumor progression and can improve survival rates in patients. Additionally, cabozantinib is being studied for its potential in treating other types of cancers, such as thyroid cancer and prostate cancer, due to its ability to block pathways critical for tumor growth and angiogenesis. It is typically administered orally, allowing for convenient outpatient treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :